正电子发射显像剂O-(2-[18F]氟乙基)-L-酪氨酸的新型前体的合成

设计合成了5种新型正电子发射断层显像剂[O-(2-[¹⁸F]氟乙基)-L-酪氨酸的前体化合物：N-叔丁氧羰基-O-(2-甲磺酰/对硝基苯磺酰)-氧乙基-L-酪氨酸甲酯(9a,11a)和N-叔丁氧羰基-O-(2-甲磺酰/对甲苯磺酰/对硝基苯磺酰)-氧乙基-L-酪氨酸叔丁酯(9b,10b,11b)。 这些化合物以L-酪氨酸为原料,先与甲醇发生酯化反应或与乙酸叔丁酯进行酯交换,再用叔丁氧羰基保护氨基,最后以碳酸钾为碱、18-冠-6为相转移催化剂与乙二醇的磺酸酯在丙酮溶液中加热回流形成目标化合物,总收率为30%～67%。     

HPLC-ELSD在1-脱氧野尻霉素,葡萄糖和葡萄糖胺的杂质分析中的应用

建立了一种高效液相分析方法可用于1-脱氧野尻霉素,葡萄糖和葡萄糖胺的杂质分析.该方法以乙腈/水酸性系统为流动相体系,色谱柱采用WatersAtlantis HILIC Silica(5 μm,150×4.6 mm),以蒸发光散射检测器(ELSD)进行检测,采用主成分自身对照法用于杂质含量的计算.方法验证结果表明,1-脱氧野尻霉素,葡萄糖和葡萄糖胺在0.008～0.04 mg/mL范围内峰面积对质量浓度呈现良好的线性,线性回归系数分别为0.9993,0.9998,0.9996.1-脱氧野尻霉素,葡萄糖和葡萄糖胺的最低检测浓度分别为0.0045,0.0040,0.0039 mg/mL.3种化合物在0.02,0.04,0.08 mg/mL 3种质量浓度点的重现性良好,RSD%均小于10%.     

高效液相色谱-串联质谱法同时测定盐酸拉贝洛尔中三种杂质

建立高效液相色谱-串联质谱法同时测定盐酸拉贝洛尔中2-羟基-5-[1-羟基-2-[(1-甲基-3-苯丙基)氨基]乙基]苯甲酸、2-羟基-5-[1-羟基-2-[(1-甲基-3-苯丙基)氨基]乙基]苯甲酸甲酯和2-羟基-5-(2-(4-苯基丁-2-氨基)乙酰)苯甲酰胺的含量。采用Agilent Eclipse XDB-C18柱（250 mm×4.6 mm,5μm）为分离柱,以0.1%（质量分数）的乙酸溶液为流动相A,乙腈-0.1%的乙酸溶液（体积比为1∶1）为流动相B,流量为1.5 mL/min,梯度洗脱,柱温为40℃,进样体积为10μL,离子源为大气压化学电离源,采用多反应监测模式。三种杂质的质量浓度分别在1.0160～203.20、1.0320～206.40、1.0370～207.40 ng/mL范围内与色谱峰面积线性相关,相关系数均大于0.999,3种化合物的检出限均为0.03ng/mL,定量限均为0.10 ng/mL。样品平均回收率分别为95.3%、92.4%、91.9%,测定结果的相对标准偏差分别为1.44%、1.46%、1.11%(n=9)。该方法可用于同时测定盐酸拉贝洛尔中3...     

柱前衍生高效液相色谱法分离分析1-氮杂双环[2,2,2]辛-3-基胺对映异构体

1-氮杂双环[2,2,2]辛-3-基胺是制备5-羟色胺拮抗剂药物盐酸帕洛诺司琼等的重要中间体,手性帕洛诺司琼可以通过中间体的手性分离来制备。用柱前衍生化-反相高效液相色谱法对1-氮杂双环[2,2,2]辛-3-基胺对映体进行分离并建立了检测方法。结果表明,用2,3,4,6-四-O-乙酰基-β-D-葡萄糖异硫氰酸酯(GITC)为柱前手性衍生化试剂,C18柱(300mm×4.6mm,5μm)为色谱柱,可将1-氮杂双环[2,2,2]辛-3-基胺对映体分离,其它色谱条件:流动相组成为[甲醇-乙腈-0.01mol/L四丁基溴化铵(20∶10∶75,V/V)]-(三乙胺)0·1%-(冰醋酸)0.15%,流速0.7mL/min,检测波长为266nm。在选择的测定条件下,衍生后的两非对映异构体分离度达4以上。     

高效液相色谱-电感耦合等离子体质谱法测定化妆品中2-溴-2-硝基-1,3-丙二醇

建立了高效液相色谱-电感耦合等离子体质谱(HPLC-ICP-MS)测定化妆品中2-溴-2-硝基-1,3-丙二醇的方法。采用ZORBAX RX-C_8色谱柱(150×2.1 mm,5μm)进行分离,以甲醇-水-5%磷酸(10∶985∶5,用2 mol/L NaOH调至pH 3.0)为流动相,流速为0.7 m L/min,柱温为室温。结果显示,2-溴-2-硝基-1,3-丙二醇在2.5 min处出峰,其线性范围为0.01~1.0 mg/L,相关系数为0.999 9。不同基质化妆品的方法检出限均为1.0μg/g,回收率为94.6%~101.3%,相对标准偏差(RSD,n=6)为1.5%~4.5%。该方法快速、准确、灵敏、无干扰,适用于化妆品中2-溴-2-硝基-1,3-丙二醇的定性定量测定。     

反相高效液相色谱法测定α-[(二甲基氨基)亚甲基]-β-酮基-2-噻吩丙腈

应用反相高效液相色谱法测定α-[(二甲基氨基)亚甲基]-β-酮基-2-噻吩丙腈(IDP-3)的含量。采用Phenomex C18色谱柱(4.6 mm×250 mm,5μm),并以不同比例混合的甲醇和水的混合溶液作梯度淋洗;检测波长为330 nm,外标法定量。在优化的色谱条件下,IDP-3与其它共存物质能够良好地分离。IDP-3的质量浓度在10.0～100 mg.L-1范围内与峰面积呈线性关系,检出限(3S/N)及测定下限(10S/N)分别为0.01 mg.L-1和0.035 mg.L-1。精密度试验表明,日内相对标准偏差(n=6)在0.43%～0.64%之间。     

超声萃取-高效液相色谱法测定烟草中β-D-吡喃葡萄糖-3-氧代-α-紫罗兰醇苷

建立了一种用超声波辅助萃取-高效液相法测定烟草中β-D-吡喃葡萄糖-3-氧代-α-紫罗兰醇苷含量的新方法。以甲醇为萃取溶剂,超声萃取条件经过正交实验优化,优化后的条件为料液比1:40(m/V,g/mL)、萃取功率160W,萃取时间20 min。所得萃取液经大孔吸附树脂柱层析法分离后,用Waters SunFireC18(150 mm×4.6 mm,5μm)色谱柱分离,紫外检测器(波长为243nm)检测,流动相为V(乙腈):V(水)=20:80;流速1 mL/min。β-D-吡喃葡萄糖-3-氧代-α-紫罗兰醇苷在0.01～1 mg/mL范围内线性关系良好,相关系数为0.9994,相对标准偏差为1.8%,检出限为0.05μg/mL,平均回收率为87.80%。该方法适用于β-D-吡喃葡萄糖-3-氧代-α-紫罗兰醇苷的定量分析。     

柱前衍生-反相高效液相色谱法测定2-去氧葡萄糖的含量

采用对氨基苯甲酸乙酯为衍生化试剂,建立柱前衍生化反相高效液相色谱法(RP-HPLC)测定2-去氧葡萄糖的含量.结果表明,最适的衍生化条件为反应温度85℃,反应时间1.5 h,衍生化试剂(ABEE)和单糖(2-DG/Glu)的摩尔比为25∶1;色谱条件为色谱柱Hypersil ODS2 (250 mm×4.6 mm,5μm),流动相为0.02％TFA-乙腈(80∶20,V/V),流速1.0 mL/min,波长307 nm.本方法在1～700 mg/L浓度范围内与峰面积呈良好的线性关系(r-0.9999);定量限(S/N-10)及检出限(S/N-3)分别为450和100 μg/L;平均加标回收率为101.7％;RSD为0.7％;日内及日间精密度均小于0.7％.表明本方法灵敏度高,测定结果准确,重复性好,可用于2-去氧葡萄糖样品的准确定量分析.     

整合素αvβ3 靶向PET探针 18 F-c(RGDfK) 在Cu(Ⅰ)催化体系中的点击合成

通过2-叠氮乙基对甲苯磺酸酯的18F-亲核取代反应, 制备了[18F]2-氟叠氮乙烷, 并与丙炔酸修饰的c(RGDfK)反应, 采用常用的CuSO4/NaVc催化体系, 并尝试了CuI(s)和CuI/NH4OH 2种催化体系, 通过点击化学方法合成了整合素αvβ3靶向PET探针[18F]氟乙基-1,4-取代1,2,3-三唑c(RGDfK)[18F-c(RGDfK)]. 在CuSO4/NaVc的催化下, 18F-c(RGDfK)的总合成时间约为60 min, 总收率62%(从[18F]F-起计, 经过衰变校正). 实验结果表明, 点击化学方法高效便捷, 适于多肽的18F标记.     

2-[4-(2,6-二氟苯基)噻唑-2-基]-3-羟基丙烯腈衍生物的合成及生物活性

为了寻找生物活性良好的噻唑基丙烯腈类化合物, 利用2-[4-(2,6-二氟苯基)噻唑-2-基]乙腈(3)分别与取代氯甲酸酯4和取代苯基异氰酸酯6在碱存在下反应, 合成了8个2-[4-(2,6-二氟苯基)噻唑-2-基]-3-羟基-3-烃氧基丙烯腈化合物5和7个2-[4-(2,6-二氟苯基)噻唑-2-基]-3-羟基-3-取代苯胺基丙烯腈化合物7, 均为首次报道的丙烯腈类化合物. 化合物结构经1H NMR, IR, MS和元素分析表征. 初步生物活性测定结果表明, 在试验浓度下, 目标化合物均具有一定的杀虫和抑菌活性, 其中化合物5f和5h在100 mg/L浓度下对炭疽病菌的抑制率达95%; 化合物5g和7d在250 mg/L浓度下对棉红蜘蛛的致死率达85%.     

高效液相色谱法测定生活饮用水中的苯并[a]芘

建立高效液相色谱二极管阵列检测器检测生活饮用水苯并[a]芘的测定方法。采用C18反相色谱柱(150mm×4.6 mm,5μm),在流动相为甲醇–水(体积比为90∶10)、流量1.0 mL/min、检测波长295 nm、柱温35℃、进样体积20μL的条件下测定生活饮用水中苯并[a]芘。该方法检出限为6 ng/L,线性范围0～100 ng/mL,加标回收率为88.1%～93.4%,测定结果的相对标准偏差为1.06%(n=9)。该法样品预处理简单,分离度高,分析时间短,适用于生活饮用水中苯并[a]芘的准确定性定量测定。     

高效液相色谱法测定血清中头孢噻肟浓度

 用固相萃取法处理样品，以扑热息痛为内标物、甲醇－醋酸钠／醋酸缓冲溶液作流动相，采用反相高效液相色谱法测定血清中头孢噻肟的浓度。头孢噻肟和内标物的平均回收率分别为９６．７％和９７．７％，头孢噻肟血清浓度在１０ｍｇ／Ｌ至１５０ｍｇ／Ｌ范围内有良好线性关系，最低检测浓度为２ｍｇ／Ｌ，日内和日间相对标准偏差分别在３．０％和４．１％以内。结果表明方法准确、简便。     

高效液相色谱-荧光检测器法测定2-噁唑烷酮的含量

建立一种利用高效液相色谱结合荧光检测器准确测定2-噁唑烷酮含量的方法。样品中的2-噁唑烷酮和占吨氢醇在60℃的条件下衍生70 min后,直接进样分析。采用月旭XB-C18色谱柱,流动相为0.02 mol/L乙酸钠水溶液和乙腈,检测器波长为λex=213 nm,λem=308 nm,流速1.0 mL/min,柱温35℃的条件下。2-噁唑烷酮浓度在0.5~50.0mg/mL时,线性关系良好(R2=0.9995),检测限和定量限分别为0.005 mg/L、0.016 mg/L。该方法准确、灵敏、快速,适用于2-噁唑烷酮含量的检测。     

高效液相色谱法测定奶粉和液态奶中的三聚氰胺

建立了奶粉和液态奶中三聚氰胺的高效液相色谱（HPLC）检测方法。经阳离子交换固相萃取柱净化后的样品采用HPLC测定。优化的色谱条件：C18柱（4.6 mm ×200 mm,5 μm）,流动相为乙腈-0.01 mol/L庚烷磺酸钠（pH 3.3）（体积比为10∶90）,流速为1.0 mL/min,检测波长为236 nm,柱温为40 ℃,进样量为20 μL。方法的线性范围为1~500 mg/L,检出限为0.2 mg/kg （S/N=3）,定量限为1 mg/kg （S/N=15）,回收率为81.4%~83.7%,相对标准偏差为3.3%~8.5%（n=6）。     

反相离子对色谱法测定脱氧精胍菌素药物中的主成分

建立了反相离子对色谱法分离测定脱氧精胍菌素药物中主成分的方法。分别考察了色谱柱类型、离子对试剂种类及浓度、缓冲盐浓度和流动相pH值等参数对实验结果的影响。确定了分离脱氧精胍菌素的最佳条件: C18色谱柱(250 mm×4.6 mm, 5 μm);以5 mmol/L磷酸氢二钾水溶液(含5 mmol/L戊烷磺酸钠,pH 3.6±0.3)-乙腈(90:10, v/v)为流动相,流速为1.0 mL/min;检测波长为210 nm;柱温为30 ℃;进样量为20 μL。该方法实现了对脱氧精胍菌素的良好分离,且线性关系良好,检出限可达0.5 mg/L。     

Rapid Detection of the Residual Kryptofix 2.2.2 Levels in [18F]-Labeled Radiopharmaceuticals by Ultra-Performance Liquid Chromatography Tandem Mass Spectrometry

A fast and sensitive ultra-performance liquid chromatography-tandem mass spectrometric (UPLC/MS/MS) method was developed and validated for determination of the residual levels of Kryptofix 2.2.2 (K222) in [¹⁸F]-labeled radiopharmaceuticals. The analytical time was only 3 min, and the injection volume was 5 μL. An electrospray ionization source was used in the positive mode (ESI⁺) for UPLC/MS/MS. The analytical measurements were performed in the multiple reaction monitoring (MRM) mode. The calibration curve at the spiked concentrations of 2–500 ng/mL for K222 showed good linearity. The intra- and inter-day precisions were not more than 5%. The accuracy satisfied the requirement of quality control analysis, the recoveries were found to be 80–120%. This method was successfully applied to detect the residue of K222 in [¹⁸F]-fluorodeoxyglucose [(¹⁸F)FDG], [¹⁸F]-fluoromisonizole[(¹⁸F)FMISO], 3′-deoxy-3′-[¹⁸F]-fluorothymidine [(¹⁸F)FLT], and two new [¹⁸F]-labeled radiopharmaceuticals 4-[-(2-[¹⁸F]fluoroethoxy) methyl]-1-[2-(2-methyl-5-nitro-1H- imidazol-1-yl) ethyl]-1H-1,2,3-triazole (named as ¹⁸F-BNU-1) and 4-[-(2-[¹⁸F] fluoroethoxy) methyl]-1-[2-(2-nitro-1H-imidazol-1-yl) ethyl]-1H-1,2,3-triazole (named as ¹⁸F-BNU-2) produced in our lab.     

Determination of Total Radiochemical Purity of [18F]FDG and [18F]FET by High-Performance Liquid Chromatography Avoiding TLC Method

The goal of this work was to present two high-performance liquid chromatography (HPLC) method that could be applied for the determination of the total radioactive purity of 2-deoxy-2-[¹⁸F]fluoro-D-glucose ([¹⁸F]FDG) and O-(2-[¹⁸F]fluoroethyl)-L-tyrosine ([¹⁸F]FET). The separation of [¹⁸F]fluoride ions, [¹⁸F]FET and [¹⁸F]FET intermediate was accomplished on LiChrosper RP-18, 250?×?4 mm, 5 µm (Merck) analytical column. For mobile phase 10 mM potassium dihydrogen phosphate buffer at pH7 (A) and acetonitrile (B) was used: 0–2 min: 15% B; 2–12 min: 85% B; 12–15 min: 15% B, respectively. Analysis of [¹⁸F]FDG was performed using LiChrosper 100 NH₂, 250?×?4.5 mm, 5 µm (Merck) analytical column. The initial mobile phase composition was 10 mM KH₂PO₄ buffer (pH7) and acetonitrile (15:85, v/v) and the acetonitrile ratio was decreased to 15% at 2 min after the sample injection and held for 5 min. Complete elution of [¹⁸F]fluoride ions from stationary phases could be achieved by adding 10 mg/mL K[¹⁹F]F to radioactive samples in a ratio 1:1 during the sample preparation. Recovery of [¹⁸F]fluoride ions ranged from 99.5 to 100.6%. The validation of the developed methods showed good results for linearity (r²?=?0.9981–0.9996), specificity (R_S?=?3.7–10.2), repeatability (%Area RSD_%?=?1.2–4.3%) and limit of quantitation (LOQ?=?1.6–4.5 kBq). During the cross-validation similar radiochemical purity values were obtained by the novel HPLC methods and thin layer chromatography performed according to the recommendations of the Ph. Eur. monographs.

     

[89Zr]-Pertuzumab PET Imaging Reveals Paclitaxel Treatment Efficacy Is Positively Correlated with HER2 Expression in Human Breast Cancer Xenograft Mouse Models

Paclitaxel (PTX) treatment efficacy varies in breast cancer, yet the underlying mechanism for variable response remains unclear. This study evaluates whether human epidermal growth factor receptor 2 (HER2) expression level utilizing advanced molecular positron emission tomography (PET) imaging is correlated with PTX treatment efficacy in preclinical mouse models of HER2+ breast cancer. HER2 positive (BT474, MDA-MB-361), or HER2 negative (MDA-MB-231) breast cancer cells were subcutaneously injected into athymic nude mice and PTX (15 mg/kg) was administrated. In vivo HER2 expression was quantified through [⁸⁹Zr]-pertuzumab PET/CT imaging. PTX treatment response was quantified by [¹⁸F]-fluorodeoxyglucose ([¹⁸F]-FDG) PET/CT imaging. Spearman’s correlation, Kendall’s tau, Kolmogorov–Smirnov test, and ANOVA were used for statistical analysis. [⁸⁹Zr]-pertuzumab mean standard uptake values (SUV_mean) of BT474 tumors were 4.9 ± 1.5, MDA-MB-361 tumors were 1.4 ± 0.2, and MDA-MB-231 (HER2−) tumors were 1.1 ± 0.4. [¹⁸F]-FDG SUV_mean changes were negatively correlated with [⁸⁹Zr]-pertuzumab SUV_mean (r = −0.5887, p = 0.0030). The baseline [¹⁸F]-FDG SUV_mean was negatively correlated with initial [⁸⁹Zr]-pertuzumab SUV_mean (r = −0.6852, p = 0.0002). This study shows PTX treatment efficacy is positively correlated with HER2 expression level in human breast cancer mouse models. Molecular imaging provides a non-invasive approach to quantify biological interactions, which will help in identifying chemotherapy responders and potentially enhance clinical decision-making.     

高效液相色谱法测定斯帕沙星注射液

 采用高效液相色谱法对斯帕沙星注射液中的主成分进行定量分析。色谱条件 :色谱柱为美国Waters公司的SymmetryC18(5 μm ,15 0mm× 3 9mmi d )不锈钢柱 ,检测波长为 2 98 8nm ,柱温 30℃ ,流动相为 0 2 %KH2 PO4缓冲液 (pH 3 2 ) CH3 CN CH3 OH(体积比为 80∶15∶5 )的混合溶液 ,进样量为 10 μL ,流速为 1 0mL/min。在该色谱条件下的测定结果是 :以斯帕沙星峰计算柱效为 15 30 0理论板数 /m ;斯帕沙星的线性范围为 39 94mg/L～ 199 6 8mg/L ,相关系数r =0 9999;平均加样回收率为 10 0 1% ,RSD为 0 72 %     

反相高效液相色谱法测定荧光增白剂CBS中N,N-二甲基甲酰胺的残留量

建立了反相高效液相色谱外标法检测荧光增白剂CBS(即CF-351)中N,N-二甲基甲酰胺(DMF)残留量的方法。使用Accurasil C18(150 mm×4.6 mm,5 μm)反相液相色谱柱,以甲醇-水为流动相梯度洗脱,流速为1.0 mL/min,检测波长为205 nm,柱温为30 ℃,进样量为5 μL。在上述条件下,在DMF质量浓度为0.19～141 mg/L范围内,其峰面积与质量浓度的线性关系良好。在加标水平（用质量分数表示）为0.2344%和0.4678%时,回收率为98.4%～107.3%。本方法最低检出限(LOD)为0.019%（质量分数）,峰面积的相对标准偏差(RSD)为1.73%。此方法可快速、准确地测定出荧光增白剂CBS中DMF的残留量。